Out Of Body Operation WFtv.com, FL - In a world's first, Dr. Kato and his transplant team removed six of Brooke's major organs simultaneously. They took out her stomach, pancreas, liver, ...
Donated organs can give people a new life Pasadena Star-News, CA - Nov 20, 2008 Unlike waiting for a kidney transplant, which is a time-based wait list, the liver transplant list is based on how sick a patient is, Selby explained. ...
Families sue after organ transplants lead to cancer deaths Indianapolis Star, United States - Nov 10, 2008 By Shari Rudavsky Anthony Taylor had hoped his kidney and liver transplant would save his life. Instead, the new organs gave him skin cancer, which caused ...
HOW I SEE IT: Some special reasons for Thanksgiving Culpeper Star Exponent, VA - Nov 27, 2008 Suddenly, you find yourself at the University of Virginia Children?s Hospital talking to transplant surgeons about donating a portion of your liver to save ...
Organ transplant recipients say thanks, share stories for National ... The Plain Dealer - cleveland.com, OH - Nov 17, 2008 David Grier, a TRIO member who received a kidney transplant in 1997, and a kidney and liver transplant in 2007, said recipients don't always get a chance to ...
Cancer treatment for pets increasingly common Times Daily (registration), AL - Nov 9, 2008 The tumor on his liver drained the energy from the beloved family member who loved to play by Spring Park in Tuscumbia. The family opted for Tank to have ...
DeMATTEO: Susan Davis lends a little perspective to all our problems New Haven Register (subscription), CT - Nov 16, 2008 Ed received a liver transplant on Nov. 20, 1999, and then helped the foundation by promoting awareness of the gift of life through transplantation. ...
Other News To Note TMCnet - The company needs financing to completion clinical trials for its SEPET Liver Assist Device. ? Argos Therapeutics Inc., of Durham, NC, and Universit? de ...
Micromet, Inc. Reports Second Quarter 2008 Financial Results Earthtimes (press release), UK - 11 minutes ago Less common adverse events included transient neutropenia and thrombocytopenia, transient increase of liver enzymes and central nervous system events, ...MITI
Allos Therapeutics Reports 2008 Second Quarter Results MarketWatch - Aug 5, 2008 ... is bioactivated by the enzyme DT-diaphorase, or DTD, which we believe is over-expressed in many tumors, including lung, colon, breast and liver tumors. ...ALTH
Surgery may be option for advanced liver cancer Reuters UK, UK - Jul 16, 2008 ... class A. Kokudo said that patients with worse liver function (class B) may not be good candidates for surgery, but depending on tumor characteristics, ...
Radiofrequency thermal ablation of liver tumors - H Rhim, GD Dodd - Journal of Clinical Ultrasound, 1999 - doi.wiley.com ... Patients who develop tumors outside the liver are no longer considered candidates
for repeat ablations of livertumors unless the extrahepatic disease can be re ...
Radiofrequency Ablation of Malignant Liver Tumors - SA Curley - Annals of Surgical Oncology, 2003 - Soc Surgical Oncol ... used in patients who did not meet the criteria for resectability of hepatocellular
carcinoma (HCC) and metastatic livertumors, and yet were candidates for a ...
Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. - AS Pearson, F Izzo, RY Fleming, LM Ellis, P Delrio … - Am J Surg, 1999 - ncbi.nlm.nih.gov ... The majority of patients with primary or metastatic malignancies confined to the liver are not candidates for resection because of tumor size, location ...
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates - LJ Herrera, HC Fernando, Y Perry, WE Gooding, PO … - The Journal of Thoracic and Cardiovascular Surgery, 2003 - Elsevier ... in patients not considered candidates for surgery ... of complications, radiographic
evidence of tumor response after ... Results from liver RFA suggest that larger ...
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. - GR Hankins, AT De Souza, RC Bentley, MR Patel, JR … - Oncogene, 1996 - ncbi.nlm.nih.gov M6P/IGF2 receptor: a candidate breast tumor suppressor gene. ... LOH) at this locus
with mutations in the remaining allele in human livertumors. ...
Value of Three-dimensional US for Optimizing Guidance for Ablating Focal Liver Tumors - SC Rose, TI Hassanein, DW Easter, RA Gamagami, M … - Journal of Vascular and Interventional Radiology, 2001 - Soc Intervent Radiol ... A number of image-guided techniques have been developed for treatment of focal liver tumors in patients who are not candidates for operative resection. ...
Source: Google Scholar
Tumor Response May Determine Best Liver Transplant Candidates
WEDNESDAY, Aug. 16 (HealthDay News) -- In liver cancer patients, the effectiveness of treatment to reduce tumor size may be a better way of determining a patient's eligibility for transplant than the traditional method of assessing the size and number of tumors, also known as the Milan criteria, a new study says.
Liver transplantation is considered an effective treatment for early-stage hepatocellular carcinoma (HCC). Tumors are treated in order to bridge the waiting time before a liver becomes available for transplant. There's been little research on whether this treatment may have an effect on transplant patient survival.
This study included 96 HCC patients who received periodic transarterial chemoembolization (TACE) prior to having a liver transplant. The TACE treatment -- designed to halt or slow tumor growth -- was repeated every six weeks and every time the patients had a CT scan to assess tumor growth.
Of these 96 patients, 16 met the Milan criteria and were immediately put on the transplant list, while 34 other patients initially exceeded the Milan criteria but responded to TACE and were placed on the transplant list.
After five years, 94 percent of the patients in the first group had no cancer recurrence, compared to 75 percent of patients in the second group.
Since there wasn't a significant difference between the two groups, the findings suggest that the Milan criteria may not be crucial in predicting cancer recurrence following liver transplant, conclude the team from Johannes Gutenberg University in Mainz, Germany.
"Our study suggests that oncological control reached by the scheduled TACE pretreatment during the waiting time is obviously of greater importance for the long-term prognosis than downstaging (reducing tumor size) itself," the study authors wrote.
The study was published in the August issue of Liver Transplantation.
More information
The American Cancer Society has more about liver cancer.
